Drug    DrugBank | All Description Patterns💬 Info on mouse-over

8 / 17,542 descriptions

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY
On map, Yellow: Drug target genes
Disease ID
 1  Oxycodone/naloxone prolonged release t  Naloxone  [5] D01340, D03783, D05312, D05462, D08249 💬  [3] OPRD1, OPRK1, OPRM1 💬  [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway  [1] 226 💬 
 2  Oxycodone/naloxone prolonged release tablets  Naloxone  [5] D01340, D03783, D05312, D05462, D08249 💬  [3] OPRD1, OPRK1, OPRM1 💬  [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway  [1]  6  💬 
 3  Oxycodone/naloxone prolonged release tablets 10 mg /5 mg  Naloxone  [5] D01340, D03783, D05312, D05462, D08249 💬  [3] OPRD1, OPRK1, OPRM1 💬  [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway  [1]  6  💬 
 4  Oxycodone/naloxone prolonged release tablets 10/5 mg  Naloxone  [5] D01340, D03783, D05312, D05462, D08249 💬  [3] OPRD1, OPRK1, OPRM1 💬  [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway  [1] 226 💬 
 5  Oxycodone/naloxone prolonged release tablets 20 mg /10 mg  Naloxone  [5] D01340, D03783, D05312, D05462, D08249 💬  [3] OPRD1, OPRK1, OPRM1 💬  [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway  [1]  6  💬 
 6  Oxycodone/naloxone prolonged release tablets 20/10 mg  Naloxone  [5] D01340, D03783, D05312, D05462, D08249 💬  [3] OPRD1, OPRK1, OPRM1 💬  [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway  [1] 226 💬 
 7  Oxycodone/naloxone prolonged release tablets 5 mg /2.5 mg  Naloxone  [5] D01340, D03783, D05312, D05462, D08249 💬  [3] OPRD1, OPRK1, OPRM1 💬  [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway  [1]  6  💬 
 8  Oxycodone/naloxone prolonged release tablets 5/2.5 mg  Naloxone  [5] D01340, D03783, D05312, D05462, D08249 💬  [3] OPRD1, OPRK1, OPRM1 💬  [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway  [1] 226 💬